# ClinicalTrials.gov record NCT04750460

> PeptideScanner retained ClinicalTrials.gov record NCT04750460 at 2026-07-30T19:32:59.860Z. Its registry update date was 2022-11-10, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct04750460-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2022-11-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04750460-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04750460-teriparatide-v1.json
- Content SHA-256: `87905f74c66ac7cb112e9af9bb798cc1084f2d2c4fad255639c67e4f84c26ea6`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04750460 ([`ctg-observation-nct04750460-2022-11-10-3f17903a9155`](#source-ctg-observation-nct04750460-2022-11-10-3f17903a9155))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04750460 at 2026-07-30T19:32:59.860Z. Its registry update date was 2022-11-10, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct04750460-2022-11-10-3f17903a9155`](#source-ctg-observation-nct04750460-2022-11-10-3f17903a9155))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04750460 at 2026-07-30T19:32:59.860Z. Its registry update date was 2022-11-10, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct04750460-2022-11-10-3f17903a9155`](#source-ctg-observation-nct04750460-2022-11-10-3f17903a9155))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04750460-2022-11-10-3f17903a9155`](#source-ctg-observation-nct04750460-2022-11-10-3f17903a9155))

## Sources

<a id="source-ctg-observation-nct04750460-2022-11-10-3f17903a9155"></a>
- **ClinicalTrials.gov record NCT04750460 · retained source version 2022-11-10:3f17903a91558dd95dee0b4102d4e7082f133d513930c502d71e76c11c9832dc** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04750460) (`ctg-observation-nct04750460-2022-11-10-3f17903a9155`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04750460." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04750460-teriparatide-v1.json SHA-256: 87905f74c66ac7cb112e9af9bb798cc1084f2d2c4fad255639c67e4f84c26ea6.